Related Experiment Video

Updated: May 18, 2026

Identification of OTX1 and OTX2 As Two Possible Molecular Markers for Sinonasal Carcinomas and Olfactory Neuroblastomas
07:00

Identification of OTX1 and OTX2 As Two Possible Molecular Markers for Sinonasal Carcinomas and Olfactory Neuroblastomas

Published on: February 28, 2019

OTX2 represses myogenic and neuronal differentiation in medulloblastoma cells

Ren-Yuan Bai1, Verena Staedtke, Hart G Lidov

  • 1Department of Neurosurgery, Johns Hopkins University School of Medicine, Baltimore, Maryland 21231, USA. rbai1@jhmi.edu

Cancer Research
|September 19, 2012
PubMed

Insights

The transcription factor OTX2 suppresses differentiation in medulloblastoma. Reducing OTX2 levels promotes cell differentiation and survival, revealing its oncogenic role in this brain tumor.

Area of Science:

  • Neuroscience
  • Developmental Biology
  • Cancer Research

Background:

  • OTX2, a transcription factor crucial for brain development, is frequently overexpressed or amplified in medulloblastomas.
  • The precise mechanisms by which OTX2 contributes to medulloblastoma pathogenesis remain unclear.

Purpose of the Study:

  • To elucidate the mechanistic role of OTX2 in medulloblastoma.
  • To investigate OTX2's function as a transcriptional repressor and its impact on cell differentiation.

Main Methods:

  • Investigated OTX2's transcriptional activity and DNA binding in medulloblastoma cells.
  • Utilized RNA interference to reduce OTX2 expression in vitro and in vivo.
  • Analyzed OTX2 expression in medullomyoblastoma subtypes.

Main Results:

  • OTX2 acts as a transcriptional repressor, inhibiting myogenic and neuronal differentiation via its homeobox domain binding to the MyoD1 enhancer.
  • Reducing OTX2 expression in medulloblastoma cells induced differentiation and improved survival in a mouse model.
  • Loss of OTX2 expression correlated with myogenesis in medullomyoblastoma.

Conclusions:

  • OTX2 functions as a differentiation suppressor in medulloblastoma through its homeobox domain.
  • The loss of OTX2 is associated with muscle cell differentiation in medullomyoblastoma, providing insight into tumor cell of origin.
  • OTX2's oncogenic mechanism involves repressing the differentiation potential of medulloblastoma cells.

More Related Videos

Inducible and Reversible Dominant-negative (DN) Protein Inhibition08:35

Inducible and Reversible Dominant-negative (DN) Protein Inhibition

Published on: January 7, 2019

Primary Cell Cultures to Study the Regeneration Potential of Murine Müller Glia after MicroRNA Treatment10:16

Primary Cell Cultures to Study the Regeneration Potential of Murine Müller Glia after MicroRNA Treatment

Published on: March 28, 2022

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...